Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05544591
What this trial is testing

Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 93
Large-scale testing (Phase 3)Not Yet RecruitingNCT07783425
What this trial is testing

Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 1,375
Not applicableEnded earlyNCT06219213
What this trial is testing

Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin

Who this might be right for
Skin Dryness
SCF Pharma 21
Not applicableStudy completedNCT01326910
What this trial is testing

Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema

Who this might be right for
Atopic Dermatitis
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06395948
What this trial is testing

A Study Evaluating APG777 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Apogee Therapeutics, Inc. 470
Testing effectiveness (Phase 2)UnknownNCT05694884
What this trial is testing

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
ASLAN Pharmaceuticals 75
Not applicableActive Not RecruitingNCT06230991
What this trial is testing

A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema

Who this might be right for
Atopic Eczema
Chinese University of Hong Kong 30
Not applicableEnded earlyNCT03198390
What this trial is testing

Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions

Who this might be right for
Atopic DermatitisHidradenitis SuppurativaContact Dermatitis+1 more
University of Arizona 100
Post-approval studies (Phase 4)Looking for participantsNCT06004986
What this trial is testing

DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema

Who this might be right for
Atopic DermatitisAtopic Dermatitis Eczema
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 216
Early research (Phase 1)Enrolling By InvitationNCT06744569
What this trial is testing

A Phase I Clinical Trial to Evaluate CU-10101 Unguent

Who this might be right for
Atopic Dermatitis
Cutia Therapeutics（Wuxi）Co.,Ltd 64
Testing effectiveness (Phase 2)Study completedNCT02669888
What this trial is testing

Indigo Naturalis in Treating Atopic Dermatitis Topically

Who this might be right for
Atopic Dermatitis
Chang Gung Memorial Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02932891
What this trial is testing

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

Who this might be right for
Atopic Dermatitis
Sun Pharmaceutical Industries, Inc. 28
Not applicableNot Yet RecruitingNCT07481019
What this trial is testing

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

Who this might be right for
Chronic Dermatological ConditionsEczemaUrticaria+2 more
National University Hospital, Singapore 250
Post-approval studies (Phase 4)Study completedNCT00557284
What this trial is testing

Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens

Who this might be right for
Atopic Dermatitis
1st Allergy & Clinical Research Center 20
Large-scale testing (Phase 3)WithdrawnNCT02677636
What this trial is testing

Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older

Who this might be right for
Atopic Dermatitis
Merz North America, Inc.
Not applicableStudy completedNCT05137093
What this trial is testing

Scratching Validation Study

Who this might be right for
Atopic Dermatitis
Philips Clinical & Medical Affairs Global 27
Early research (Phase 1)Study completedNCT00958516
What this trial is testing

Assessment of the Phototoxic Potential of LEO 29102 Cream

Who this might be right for
Atopic Dermatitis
LEO Pharma 32
Large-scale testing (Phase 3)Study completedNCT01949311
What this trial is testing

Open-label Study of Dupilumab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 2,733
Testing effectiveness (Phase 2)Study completedNCT03151148
What this trial is testing

Targeted Microbiome Transplant in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT07323719
What this trial is testing

Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.

Who this might be right for
Atopic Dermatitis (AD)
Cairo University 100
Next Page